Rapid and inexpensive gene sequencing has revolutionized our understanding of GBM (Jovcevska, 2020) by identifying, for example, the transcriptional inhibitor adipocyte enhancer binding protein 1 (AEBP1) (Kim et al., 2001) as a potential driver of GBM (Majdalawieh et al., 2020) and various other cancers associated with poor prognosis. The gene discussed is AEBP1; the disease is glioblastoma.